$20.0M
Molten Ventures led the Series B round to support the creation of an artificial intelligence imaging lab.
"There was an area to go and help these pharma companies do better clinical trials, and so that’s how the company started"
HH
Hargreave Hale AIM VCT
Venture CapitalPortfolio
1
companies
Investment by month
By category
- AI/ML£21.8M
By location
- Cambridge£21.8M
Portfolio companies
Team
LB
Lucy Bloomfield
co-manager
Recent investments
$8.5M
Hargreave Hale AIM VCT led the financing round to help accelerate the company platform and expand into new disease areas.
"The close of our Series A round marks the 'end of the beginning' and the start of a new chapter for Qureight, as we turn our focus to developing our platform and creating products in new disease areas. Our mission to extend the lives of lung and heart disease patients will be bolstered by the invaluable expertise of our new board and new senior team members, and we are looking forward to adding to our strategic biopharma collaborations."
